LigaChem Biosciences Inc.
141080.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
94
Cost of Revenue
12
Gross Profit
82
Gross Margin
87.3%
Operating Income
-16
Operating Margin
-16.6%
Net Income
6
Net Margin
6.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
11
EBITDA Margin
11.6%
2023
12/31/2023
Revenue
26
Cost of Revenue
12
Gross Profit
13
Gross Margin
52.1%
Operating Income
-61
Operating Margin
-236.7%
Net Income
-55
Net Margin
-215.9%
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
-54
EBITDA Margin
-209.1%
2022
12/31/2022
Revenue
25
Cost of Revenue
13
Gross Profit
12
Gross Margin
47.4%
Operating Income
-41
Operating Margin
-164.7%
Net Income
-34
Net Margin
-135.0%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-33
EBITDA Margin
-129.8%
2021
12/31/2021
Revenue
24
Cost of Revenue
12
Gross Profit
12
Gross Margin
49.2%
Operating Income
-27
Operating Margin
-113.6%
Net Income
-18
Net Margin
-72.7%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-13
EBITDA Margin
-54.5%
2020
12/31/2020
Revenue
37
Cost of Revenue
12
Gross Profit
25
Gross Margin
67.8%
Operating Income
-24
Operating Margin
-64.2%
Net Income
-5
Net Margin
-14.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-20
EBITDA Margin
-54.2%